StonvexLoading…
StonvexStonvexStonvexCore line items from LYTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $454.78M | $304.25M | $157.25M | $573.38M |
Operating Income | $23.91M | $19.84M | $10.97M | $35.77M |
Net Income | $15.70M | $6.35M | $7.26M | $24.38M |
EPS (Diluted) | $0.48 | $0.43 | $0.23 | $0.79 |
Total Assets | $800.55M | $396.31M | $404.87M | $396.36M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $10.33M | $6.41M | $7.14M | $3.46M |
Free Cash Flow OCF − CapEx | $29.23M | $23.01M | $-291.00K | $34.65M |
Shares Outstanding | 36.70M | 31.11M | 31.08M | 30.05M |